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In our studies on the effects of humoral antibodies on xenografts and allografts of 
rat  skin,  we  have  shown  that  the  interval  between  placement  of the  grafts  and 
administration of the serum is crucial in determining the fate of the transplanted skin 
(1,  2).  Antiserum injected at the time of transplantation  or within a  week thereafter 
has little or no detectable effects on the skin, but during the ensuing week the grafts 
become increasingly sensitive to the serum, and for a  period of 2-3 wk they can be 
acutely damaged by this agent in routine fashion.  Grafts that survive beyond 3 wk 
gradually lose their sensitivity to antiserum and at about 5-6 wk after transplantation 
they fail to respond to treatment or do so only with mild and transient inflammation 
and, rarely, some focal tissue damage. 
The period of insensitivity that occurs immediately after transplantation  appears 
to  depend  on  the  nonspecific  resistance  of new  and  regenerating  blood  vessels  to 
inflammatory stimuli, and we have described our studies on this phenomenon in the 
preceding paper (3). We present here the results of our studies on the loss of resistance 
that  occurs  in  long-standing  grafts  and  appears  to  depend  on  the  replacement  of 
donor endothelium by host cells. 
Materials and Methods 
Animals.  Pure strain and  Fa  hybrid mice of the following kinds were obtained from The 
Jackson Laboratory, Bar Harbor, Maine: A/J, B 10.D2/SgSn,  AKD2F1, B6D2F1, B6AF1, CAF~, 
and LAFx. Fisher  (Fi), Lewis (Le), and (Lewis ×  Brown  Norwary) F1 hybrid (LBN) rats were 
purchased from Microbiological  Associates, Walkersville,  Md.  CD rats were purchased from 
local dealers. 
Antisera.  Rabbit anti-mouse thymocyte serum (RAMTS), 1 rabbit anti-rat serum (RARS), 
and mouse anti-rat serum (MARS) were prepared as previously described (4). Rat anti-mouse 
serum  (RAMS)  was  prepared by injecting LBN rats with a  mixture of cells prepared from 
B10.D2  lymph nodes,  spleens,  and  thymuses  (108 cells per rat,  intraperitoneally).  The rats 
received  three injections  of cells at weekly intervals and 7 d after the last  injection  they were 
bled for the purpose of preparing a single pool of antiserum. 
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Experimental System.  Mice were thymectomized 2-3 wk before receiving rat skin grafts, and 
they were injected intraperitoneally with 0.25 ml of RAMTS 2 d before grafting, on the day of 
grafting, and on the 2nd and 4th d after placement of the grafts. In one experiment, treatment 
with RAMTS was continued for 8 wk after grafting at  a  dose of 0.2  ml administered  three 
times weekly. 
Grafting was carried out as described previously using 15- ×  20-ram pieces of rat ear skin (4). 
At various intervals  after  transplantation,  the recipients  were injected  with  RARS and  the 
effects of these injections on the grafts were studied. 
lmmunofluorescent Studies.  Grafts were excised  from their hosts and prepared for studies with 
fluorescent  antisera  as  described  previously  (3).  In  some  experiments,  the  hosts  had  been 
injected with anti-graft serum before removal of the grafts, and in these cases sections of tissue 
were stained directly with fluoresceinated anti-immunoglobulin or anti-C3 reagents. In other 
cases,  sections  of frozen skin  were  treated  in  vitro  with  MARS  or RAMS  and  then  with 
fluoresceinated anti-immunoglobulin serum of appropriate specificity. 
Results 
Effect  of MARS on  Long-Term  Rat  Skin  Grafts  That  Have  Been  Retransplanted  to  New 
Immunosuppressed  Mice.  Skin grafts that  had been maintained  in a  state of excellent 
condition  for 45-99 d  on immunosuppressed  B6AFa mice were removed  from their 
primary  hosts and  retransplanted  to new  immunosuppressed  B6AF1  mice.  In some 
cases the secondary recipients were grafted simultaneously with freshly prepared  rat 
skin;  in  other  cases  the  secondary hosts  received  only the  retransplanted  skin  and 
freshly prepared rat skin grafts were placed on separate mice that served as controls. 
All of the graft recipients  were injected with MARS  14 d  later.  The results of these 
experiments  are summarized in Table I. In none of the  12 retransplanted  grafts was 
there any sign of inflammation or tissue damage after the administration  of MARS. 
In  contrast,  14  of  15  primary  grafts  were  destroyed  by  antiserum.  Eight  of these 
primary  grafts  had  been  placed  simultaneously  with,  and  contralaterally  to,  re- 
transplanted rat skin, and seven of these eight grafts were destroyed as a  result of the 
injection of MARS. 
TABLE  I 
Sensitivity to MARS of Long-Surviving Rat Skin Grafts That Had Been 
Retransplanted to New Immunosuppressed Mice * 
Number of 
mice  Age of old grafts:~ 
Effects of MARS on grafts 
Inflammation§  Destruction 
Old  New  Old  New 
d 
Old and new grafts on same recipients 
8  66-99  0  7  0  7 
Old and new grafts on separate recipients 
4  45  0  --  0  -- 
7  --  --  7  --  7 
* Le skin grafts were regrafted to immunosuppressed mice syngeneic with the 
primary recipients, and MARS (0.5 ml intraperitoneally)  was administered 
on day 14 after retransplantation. 
Age at the time of regrafting. 
§ Edema, erythema, and local hemorrhage. 1334  RESISTANCE OF LONG-TERM  XENOGRAFTS  OF SKIN 
Retransplantation  alone does not make skin grafts resistant to antiserum at  14 d, as 
we have shown  in  an  earlier  report  (3).  Moreover,  we have,  as part  of the  present 
study,  transplanted  Le skin  to five LBN rats  and  allowed  these grafts to remain  in 
place  for 67  d.  The  grafts  were  then  removed  and  transplanted  onto  immunosup- 
pressed B6AFt mice.  14 d  after this regrafting, the secondary recipients were injected 
with  MARS.  All five of the  grafts were destroyed within  24 h.  Thus  the continued 
resistance to antiserum of retransplanted  rat skin is not an artifact of technique, and 
it  points clearly to alterations  in the long-standing grafts themselves, rather  than  in 
their hosts, as the major cause for the development of resistance to antiserum. 
Rejection  of Long-Term  Rat  Skin  Grafts  on  Retransplantation  to  New  Untreated  Recip- 
ients.  Long-standing xenografts of rat skin are completely insensitive to antisera and 
their resistance is maintained even when they are regrafted to new immunosuppressed 
hosts. They are,  however, frequently rejected  by these secondary hosts several weeks 
or months after transplantation.  Hence they are vulnerable to other, presumably cell- 
mediated, forms of immune attack. To examine such vulnerability more precisely, we 
have  removed  long-standing  grafts  and  retransplanted  them  to  untreated  mice 
syngeneic to the first  hosts.  The patterns  of rejection of these grafts were compared 
with fresh grafts of rat skin place also on untreated mice. In some instances both fresh 
and regrafted skin were placed simultaneously on the same recipients.  The results of 
these experiments  are shown in Table II. Five mice received grafts of skin that  had 
previously been in place on immunosuppressed  hosts for 50 d, and  all  of the grafts 
were rejected  acutely  7.5-10.5  d  after  regrafting  (mean  survival  time  9.5:1:  1.5)  11 
mice that received fresh rat  skin rejected their grafts acutely 6.5-8.5  d  after grafting 
(mean survival time 7.25 +  0.6). Thus, the retransplanted  skin survived for a  slightly 
but significantly longer period of time than did skin taken directly from donor rats. 
When four mice were grafted with both fresh and previously grafted rat skin, the new 
graft was in every case rejected  1-3 d  before the retransplanted  skin, an observation 
that indicates that the longer survival of regrafted skin is traceable, at least in part, to 
its  lower susceptibility  to an established  state  of transplantation  immunity.  Micro- 
TABLE II 
Fate of Long-Surviving Rat Skin Grafts after Retransplantation to New 
Untreated Mice * 
Number of mice  Time on first host  Graft survival on second host 
5 
11 
d  d 
50  9.5 "4- 1.5 
0:]:  7.25 :t: 0.6 
Old and new grafts on same recipients 
Old  New:]: 
280  11  10 
213  I1  8 
102  11  8 
72  12  10 
* Rat skin was initially grafted onto immunosuppressed B10.D2 mice, and at 
various times thereafter they were removed and placed on new nonsuppressed 
B10.D2 hosts. 
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scopic examination of sections of fixed specimens of grafts of both kinds showed that 
rejection was accompanied by a marked infiltration of the graft bed by mononuclear 
cells. 
Effect  of Placing New  Grafts of Rat  Skin  on  the Bearers of Long-Standing  Grafts.  The 
elevated resistance of long-standing grafts of rat skin is not dependent on their being 
regrafted, as shown in the following experiment. Eight mice bearing Le rat skin grafts 
of 54-152  d  duration received second grafts of Le skin. The survival times of these 
grafts are indicated in Table III.  In six cases, the second grafts were rejected much 
earlier (11 to >150 d) than the original grafts on the same recipient. In one case both 
grafts were rejected 19 d after placement of the second graft and one mouse died with 
both grafts intact 21 d  after application of the second graft. Again, there is decisive 
evidence  that  long-standing  grafts  are  susceptible  to  immunologically  mediated 
rejection, presumably of a  cellular nature, but they are clearly less susceptible than 
recently placed grafts. 
Deposition of Injected Immunoglobulin in  Long-Standing  Grafts after the Administration  of 
Anti-Graft  Sera.  We have shown that beginning at about the 4th d  after transplan- 
tation, the injection of antiserum leads to the deposition of the injected immunoglob- 
ulin  and  endogenous C3  on the  luminal  surfaces of graft  vessels  (3), and  we  have 
suggested that these deposits play a crucial role in antiserum-mediated destruction of 
grafts. We have looked, therefore, for evidence that  anti-graft antibodies react with 
endothelial antigens of long-standing grafts. Anti-graft sera  (rabbit or chicken anti- 
rat sera that had been absorbed with mouse tissues) were injected into mice bearing 
grafts of 50-150  d  duration,  and  1-2  h  later  the  grafts were removed and  frozen 
sections of them were treated with  fluorescein isothiocyanate (FITC)  conjugates of 
rabbit anti-immunoglobulin. In the case of four grafts whose hosts had been injected 
with rabbit anti-rat serum, no detectable deposits of immunoglobulin were detected; 
grafts  taken  from  four of five mice  that  received chicken  anti-rat  serum  similarly 
lacked detectable deposits of immunoglobulin, whereas the fifth graft had numerous 
vessels  that  showed deposition of chicken immunoglobulin,  though staining  in  this 
TA~L~ III 
Effect of Transplanting Fresh Rat Skin to Hosts Bearing Long-Term Grafts* 
Graft survival 
Age of old grafts:]:  Serum titer§ 
Old  New 
d  d 
152  0  23  12 
150  1:16  >211]  >21 
150  0  >42]1  10 
117  1:4  >16311  9 
54  0  19  19 
54  1:8  20  9 
54  0  39  22 
54  0  23  9 
* Le skin was transplanted contralaterally to established long-term Le grafts. 
No additional immunosuppression was applied. 
:l: Age at application of the second graft. 
§ Activity of recipient  serum as assayed in cytotoxicity tests with  rat  spleen 
cells on day of placement of second grafts. 
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instance was less intense than was observed in younger grafts that were still sensitive 
to  antiserum.  The  insensitivity  of long-standing  skin  grafts  to  antiserum  is  clearly 
associated with alterations in graft vessels that prevent significant reactivity of injected 
antibodies with endothelial cell surfaces. 
Reactivity In  Vitro of Long-Standing Skin Grafts with MARS and RAMS.  The failure of 
vessels in long-standing skin grafts to react with MARS  in vivo indicates that  graft 
antigens  have  been  altered  or  that  the  endothelium  of the  graft  vessels  has  been 
replaced  by  host  cells.  To  distinguish  between  these  two  possibilities,  grafts were 
removed from their suppressed hosts at various times after transplantation and tested 
in vitro for reactivity with MARS and RAMS.  The grafts were frozen immediately 
after removal and cut at a thickness of 2 #m. They were treated with either MARS or 
RAMS  for 30 min, washed with phosphate-buffered saline, and then treated for 30 
min with fluorescein-conjugated rabbit anti-mouse or rat IgG, reactive with both light 
and heavy chains. The unreacted anti-IgG was removed by washing again with saline 
and the grafts were examined by fluorescence microscopy and scored arbitrarily on 
the  basis  of  the  numbers  of fluorescent  vessels  observed.  These  observations  are 
summarized in Table IV, and representative examples of the appearances of stained 
grafts are presented in Figs.  1-3. 
In  all  of  10  grafts  removed  and  tested  4-14  d  after  transplantation,  there  were 
numerous  small  vessels  within  the  graft  that  displayed  bright  fluorescence  after 
treatment  with  MARS  and  FITC-anti-immunoglobulin.  An example of these reac- 
tions is shown in Fig.  1 B. In 8 of these  10 grafts, no fluorescent vessels were detected 
after treatment  with  RAMS  and  FITC-anti-immunoglobulin  (Fig.  1 A);  in  two  of 
them there were a  few positive vessels, one near the base of the graft and the other in 
the upper dermis.  Vessels in  the beds or around  the edges of the grafts were never 
observed to fluoresce after treatment with MARS and fluoresceinated anti-immuno- 
globulin  (Fig.  1 B), although  they showed variable degrees of staining when treated 
with RAMS and FITC-anti-immunoglobulin (Fig.  1 A and Table IV). These patterns 
of immunofluorescent staining of graft and host vessels are completely consistent with 
those observed when MARS was injected into graft recipients before the grafts were 
removed and treated with FITC-anti-immunoglobulin (3). 
Four long-standing rat skin grafts displayed quite different patterns of staining. In 
TABLE  IV 
Reactivity In  Vitro of Rat Skin Grafts with MARS and RAMS* 
Number  Age of 
of grafts  grafts 
Vessels in graft staining with 
Vessels in bed/edge 
staining with 
MARS  RAMS  MARS  RAMS 
d 
2  4  ++++  -  -  + 
2  6  ++++  -  -  ++++ 
1  8  ++++  -  -  + 
5  14  ++/+++  -/+  -  +/++++ 
3  73  +/++  ++++  -  ++++ 
1  109  --  ++++  -  ++++ 
* Rat  skin  was  grafted onto  immunosuppressed  B6D2FI  mice,  and  the  grafts were 
removed at various intervals and tested with MARS  or RAMS  followed by FITC- 
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Fro.  1.  Immunofluorescence photomicrographs of a rat skin xenograft sampled 4 d after grafting 
onto an immunosuppressed mouse.  Cryostat  sections were stained in vitro with  (A)  RAMS and 
fluorescein-conjugated anti-rat IgG or (B) MARS and fluorescein-conjugated anti-mouse IgG. The 
vessels in the graft bed, but not the graft itself, stain in (A); in contrast, the vessels in the graft, but 
not the graft bed, stain in (B). 
Fio.  2.  lmmunotluorescence photomicrographs of a rat skin xenogr~ ft sampled 3 mo after grafting 
and stained as in Fig.  1. Almost all graft vessels, e.g.,  the three marked V strain with RAMS (A), 
but only rare vessels stain with MARS (B). The graft epidermis at the top, and the hair follicle  (h) 
strain with MARS but not with RAMS. 
the  case of one  removed  from  its host  at  109  d  after  grafting,  there  was  widespread 
staining of graft vessels when  RAMS  was used but  no staining when  MARS  was used 
in the initial step in vitro (Fig. 2 A  and B). In three grafts removed  after 73 d  residence 
on mice,  there were again  numerous  graft  vessels fluorescing when  RAMS  was used. 1338  RESISTANCE OF LONG-TERM XENOGRAFTS OF SKIN 
Ft~.  3.  Immunofluorescence  photomicrograph  of (A) an old (3 mo) and (B) a new (14 d) rat skin 
xenograft on  mice given MARS intraperitoneally 3-4  h earlier. Cryostat sections stained with 
fluorescein-conjugated anti-mouse IgG show bright endothelial staining of the graft vessels (v) in 
(B) but not in (A). 
In these grafts, however, there were still some vessels that reacted with MARS; in two 
of the  grafts  there  was  only  a  small  number  of such  vessels,  whereas  one  graft 
contained many weakly staining vessels in the upper dermis. Again, these results are 
in complete accord with the observations, reported above, that MARS administered 
to the bearers of long-term rat skin grafts does not react detectably with graft vessels. 
Both the short- and long-term grafts showed faint but definite diffuse staining of the 
graft epidermis and connective tissue with MARS but not with RAMS. 
It is evident from these observations that in long-surviving xenografts of skin there 
is  gradual  replacement of donor endothelium  by host cells, and  that  this process is 
associated with the acquisition of resistance to antisera by long-term skin grafts. With 
respect to other constituents of skin grafts, it should be noted, as reported above, that 
long-standing grafts of rat skin are acutely rejected shortly after retransplantation  to 
new  recipients  syngeneic to  the  primary hosts.  Furthermore,  observations on  long- 
term grafts that have been removed and treated in vitro with MARS and FITC-anti- 
immunoglobulin reveal  fluorescence of both dermal  and  epidermal elements of the 
grafts (Fig. 2 B). 
Fate of Long-Term  Rat Skin Xenografls after Retransplantation to Untreated Rats of the Initial 
Donor Strain.  Rat skin that has survived for several weeks or months on immunosup- 
pressed mice is a composite of rat epidermal and dermal cells and mouse endothelial 
cells. It is resistant to MARS but is rejected when regrafted to nonimmunosuppressed 
mice. It was of interest, therefore, to determine its fate when retransplanted to rats of 
the original donor strain. Five LBN skin grafts that had survived in excellent condition 
for 50 d  on B10.D2  mice, and eight  Fisher skin grafts that  had survived for 70 d  on 
B6D2F1 mice were removed with a  narrow cuff of surrounding host skin and placed 
on rats of the LBN and Fisher types, respectively. Eight Fisher grafts that had resided 
on B6D2Fa  mice for  14 d  were removed and regrafted to Fisher rats. The fate of the 
grafts is indicated in Table V.  10 of the  11  long-term grafts were acutely rejected  7- S. V. JOOSTE, R. B. COLVIN, AND  H. J. WINN  1339 
TABLE V 
Fate of Rat Skin Regrafled to Rats after Residing for Various Periods of Time 
on Immunosuppressed Mice* 
Number of  Number 
grafts  rejected 
LBN ~  BI0.D2 -  50d ~  LBN  5  4 
Fi ~  B6D2FI -  70d --* Fi  8  8 
Fi ---~ B6D2Fa -  15d--* Fi  8  0 
* Rat (LBN or Fi) skin was transplanted to immunosuppres~'d  mice (B10.D2 
or B6D2Fa) and, at the intervals indicated, regrafted to rat~ of the original 
donor strain. 
9  d  after secondary transplantation.  The remaining long-term graft survived indefi- 
nitely, although its surrounding cuff of mouse skin was acutely rejected at 9 d. None 
of the  eight  grafts  that  were  retransplanted  after  14  d  in  residence  on  mice were 
rejected, although, as expected, the surrounding mouse skin was acutely destroyed at 
8-10  d  after grafting.  In other experiments,  we have retransplanted  skin  that  had 
been in place for 14-16 d  to animals syngeneic to the initial donors; and in none of 
22  instances were the  grafts rejected.  Evidently,  the  rejection of mouse endothelial 
cells by the secondary recipients of the long-term grafts leads  to destruction  of the 
syngeneie elements of the graft as well. The survival of one retransplanted long-term 
graft may be attributable to persistence of a sufficient number of vessels lined with rat 
endothelium,  for as we have shown above, variable amounts of donor endothelium 
persist in such grafts. 
Discussion 
It  has  been  recognized  for several  decades,  largely on  the  basis  of morphologic 
studies  carried out  directly on living tissues or on sections of fixed tissues that  had 
been removed at  various times after grafting,  that  the small blood vessels of tissue 
grafts  constitute  a  primary  focus  of  attack  by  immune  reactants.  This  is  easily 
understood because the vascular bed of the graft is the major interface between host 
and  donor  tissues,  and  vascular  changes  are  the  hallmark  of  all  inflammatory 
responses.  What  is surprising  about  the  findings  reported  here  is their  implication 
that humoral antibody can initiate damage to grafts only if it reactswith antigens of 
the donor vessels. It cannot,  of course, be formally proved that  the replacement of 
graft endothelium by host cells is the major cause of resistance of long-surviving grafts 
to antisera, but the evidence weights heavily in favor of such a  view. All of the gross 
and microscopic features of antiserum-induced damage of skin grafts can be attributed 
to vascular damage, and anti-graft antibodies and endogenous C3 are detectable on 
the luminal surfaces of graft vessels just before the development of grossly detectable 
damage.  The gradual  loss of sensitivity to antiserum  begins at  about  2-5 wk after 
grafting just at a  time when mouse cell surface antigens become detectable in graft 
vessels, and when the grafts attain complete resistance to antiserum, all but a  few of 
their vessels are lined  with cells of host  origin.  Furthermore,  the state of resistance 
develops and persists even though other elements of the graft are of donor origin. This 
is clear from the acute rejection of the grafts that occurs when they are retransplanted 
to mice syngeneic with the primary recipients, and from the staining of extravascular 
structures that is observed when long-surviving grafts are excised and treated in vitro 1340  RESISTANCE OF LONG-TERM XENOGRAFTS OF SKIN 
with  MARS  and  fluoresceinated  anti-mouse  immunoglobulin.  In  experiments  in 
which similar grafts are excised after the injection of their hosts with antiserum and 
then  treated  with  anti-immunoglobulin,  there  is  no  staining  of  graft  elements, 
indicating that antibodies had not reached extravascular cells.  Evidently, grafts are 
acutely damaged by humoral antibodies only if these agents react with endothelium, 
though  it  is  not  clear whether  this  is  due  to  the  inability  of antibodies  to  reach 
extravascular elements in sufficient concentration to incite damage or to a requirement 
for a  direct  reaction  of antibodies  with  endothelial  cells.  In  either  case  there  are 
important implications for other types of antibody-mediated damage to vascularized 
tissues, including tumors. 
In addition to providing a mechanism for the resistance of long-surviving skin grafts 
to antiserum, the observations we report here bear on an issue of recurring interest in 
the study of tissue transplantation. The notion that host cells might gradually replace 
the endothelium or other parts of grafted tissues has been put forth on a  number of 
occasions, and it has been suggested that such replacement could be partly responsible 
for the lowered state of host reactivity toward long-standing grafts. However, previous 
efforts to  demonstrate  replacement  of donor cells  by those of the  host  have  been 
unsuccessful, owing perhaps to the use of primarily vascularized organ grafts in which 
the phenomenon takes place slowly or not at all. The unequivocal demonstration of 
the replacement of donor endothelium by host cells that we describe here has been 
facilitated by the use of skin grafts, in which only small segments of donor vessels are 
preserved, and  by the use of inter-species grafts that  provides for sharp  distinction 
between host and donor cells, a feature that has been especially valuable in carrying 
out immunofluorescent studies. Although we have not demonstrated replacement of 
endothelium in allografts by direct methods, its occurrence can be inferred from the 
observations that  long-standing allografts lose their sensitivity to antisera, and they 
are rejected on regrafting to animals syngeneic to the original donor. 
Whereas the replacement of graft endothelium by host cells leads to a high level of 
resistance to humoral antibodies, its effect on sensitivity to T  cell-mediated damage 
is far less dramatic. Grafts that have survived for long periods of time on immunosup- 
pressed hosts survive longer than expected when they are regrafted to new nonsup- 
pressed recipients syngeneic to the primary hosts, but the increase in survival time is 
small and not clearly traceable to the changes in vascular endothelium. Furthermore, 
the grafts are very acutely rejected in every case in spite of their complete resistance 
to anti-graft serum. T cells are obviously more versatile and more devastating in their 
attacks on organized tissues and organs than are humoral antibodies and their action 
is only mildly attenuated when donor endothelium has been replaced by host cells. 
The  destruction  of tissues  by T  cells  is  associated  with  vascular  phenomena  and 
frequently involves vessels  of the host, but the involvement of vessels  obviously does 
not require direct reaction of the T  cells with endothelial antigens, as is the case for 
antiserum-mediated damage. That long-surviving grafts of rat skin are rejected when 
retransplanted  to  rats  of the  original  donor  strain  that  respond  primarily  to  the 
included mouse endothelium, as well as when they are grafted to new mouse recipients 
that respond primarily to nonvascular elements, provides experimental systems that 
will be useful in determining the importance of vascular damage in cell-mediated, as 
well as humorally mediated, damage to tissues. S. V. JOOSTE, R.  B. COLVIN, AND  H. J.  WINN  1341 
Summary 
Rat skin that survives for long periods of time on immunosuppressed mice becomes 
resistant  to anti-graft  serum  and  remains  so  for as  long as  it  survives.  When  long- 
standing grafts are removed and placed on new immunosuppressed mice, they remain 
resistant to antiserum for as long as they survive. The acquired resistance to antiserum 
seems,  therefore,  to be due  to changes  in  the  grafts rather  than  to changes in their 
hosts.  Furthermore,  it was found that  the acquisition  of resistance  is correlated with 
replacement  of graft  endothelium  by  host  cells,  as  demonstrated  by  the  use  of 
immunofluorescent techniques in conjunction with mouse anti-rat serum and rat anti- 
mouse serum.  Evidently, humoral antibodies are able to cause acute damage to skin 
grafts,  and  presumably  to grafts  to other  organized  tissues,  only if they  react  with 
antigens of graft endothelium. 
Long-term grafts that are retransplanted to their original donors or to rats syngeneic 
with those donors are in most cases rejected, whereas 14-d-old grafts similarly regrafted 
are in no case rejected.  Apparently, the responses of the secondary recipients  to the 
mouse endothelial antigens in long-term grafts lead to destruction of the entire grafts. 
When long-standing rat  skin xenografts are removed and placed on untreated  mice 
syngeneic  with  the  primary  hosts,  they  are  in  every  case  rejected,  although  they 
survive slightly longer than skin taken  directly from rat  donors.  Rejection  is accom- 
panied  by a  mononuclear  infiltrate  and  is  qualitatively  indistinguishable  from the 
rejection of freshly prepared  rat skin. Clearly, sensitized cells are more efficient than 
humoral antibody in destroying grafted tissues. 
We gratefully acknowledge the excellent technical assistance of Janet  Quinn, Karla Stenger, 
Eleanor Manseau, and Patricia Della-Pella. 
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